Contractor profile
MINISTRY OF DEFENCE
Active registration
UEIU6LDUQKZ2CS8
CAGE codeKB887
Primary NAICS928120
LocationSALISBURY, SP4 0JQ
Federal obligations$17M
Prime awards7
Active awards2
Latest award actionJul 21, 2026
Federal award activity
Public award recordTop federal customers
- Department of Defense4 awards$11M
- Department of Health and Human Services3 awards$6M
NAICS award mix
- 5417152 awards$6M
- 5417143 awards$5M
- 5417121 awards$4M
- 3254141 awards$2M
PSC award mix
- AC322 awards$9M
- AZ111 awards$4M
- AN131 awards$2M
- AD931 awards$1M
- AC311 awards$870,270
- AN111 awards$0
Contract vehicles
- HHSO100201100012I1 awards$2M
Potential recompetes
- Department of Defense$6M
- Department of Defense$6M
Prime award history
| Award | Agency / office | Category | Value | Dates |
|---|---|---|---|---|
| 75N93024D00010PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREAS A AND B | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | NAICS 541714PSC AN11 | $0 | Jul 15, 2024 – Not stated |
| HDTRA122C0032NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | NAICS 541715PSC AC32 | $6M | Sep 28, 2022 – Sep 27, 2027 |
| HDTRA124C0008GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | NAICS 541714PSC AC32 | $6M | Jun 10, 2024 – Dec 9, 2029 |
| HDTRA122C0035FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | NAICS 541715PSC AC31 | $870,270 | Sep 30, 2022 – Sep 29, 2025 |
| HDTRA120C0016PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | NAICS 541714PSC AD93 | $1M | Jun 15, 2020 – Jun 14, 2025 |
| HHSO10033001TTHIS TASK ORDER AWARDED TO THE DEFENCE SCIENCE AND TECHNOLOGY LABORATORY (DSTL), UK IS ISSUED TO CHARACTERIZE A NON-HUMAN PRIMATE MODEL TO IMPROVE UNDERSTANDING OF INHALATION-ACQUIRED HUMAN MELIOIDOSIS (RTOR-BIO-0007). | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | NAICS 325414PSC AN13 | $2M | Sep 7, 2012 – Mar 31, 2014 |
| HHSF223201510066CIGF::CL::IGF BAA CONTRACT TITLED, "DETERMINATION OF THE EFFICACY OF ANTIBIOTICS AGAINST MELIOIDOSIS ACQUIRED BY DIFFERENT ROUTES OF INFECTION." | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 541712PSC AZ11 | $4M | Aug 4, 2015 – Sep 29, 2019 |
Award links and obligation totals come from USAspending.gov public records.
Industries and classifications
Public points of contact
JENNIFER STEERSENIOR COMMERICAL MANAGERGovernment business
SUSAN WEBBACCOUNTS RECEIVABLEElectronic business
Names and titles are reproduced from the public registration. FedRoster does not guess or enrich personal contact details.